- Home
- ADVM vs ANEB Comparison
ADVM vs ANEB Comparison
Compare ADVM & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADVM
- ANEB
- Stock Information
- Founded
- ADVM 2006
- ANEB 2020
- Country
- ADVM United States
- ANEB United States
- Employees
- ADVM N/A
- ANEB N/A
- Industry
- ADVM Biotechnology: Biological Products (No Diagnostic Substances)
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- ADVM Health Care
- ANEB Health Care
- Exchange
- ADVM Nasdaq
- ANEB Nasdaq
- Market Cap
- ADVM 47.4M
- ANEB 39.0M
- IPO Year
- ADVM 2014
- ANEB 2021
- Fundamental
- Price
- ADVM $2.74
- ANEB $1.67
- Analyst Decision
- ADVM Strong Buy
- ANEB Strong Buy
- Analyst Count
- ADVM 5
- ANEB 2
- Target Price
- ADVM $23.80
- ANEB $5.50
- AVG Volume (30 Days)
- ADVM 297.2K
- ANEB 23.3K
- Earning Date
- ADVM 08-11-2025
- ANEB 05-13-2025
- Dividend Yield
- ADVM N/A
- ANEB N/A
- EPS Growth
- ADVM N/A
- ANEB N/A
- EPS
- ADVM N/A
- ANEB N/A
- Revenue
- ADVM $1,000,000.00
- ANEB N/A
- Revenue This Year
- ADVM N/A
- ANEB N/A
- Revenue Next Year
- ADVM $18.82
- ANEB N/A
- P/E Ratio
- ADVM N/A
- ANEB N/A
- Revenue Growth
- ADVM N/A
- ANEB N/A
- 52 Week Low
- ADVM $1.78
- ANEB $0.80
- 52 Week High
- ADVM $10.14
- ANEB $3.08
- Technical
- Relative Strength Index (RSI)
- ADVM 59.62
- ANEB 57.71
- Support Level
- ADVM $2.50
- ANEB $1.56
- Resistance Level
- ADVM $2.75
- ANEB $1.85
- Average True Range (ATR)
- ADVM 0.20
- ANEB 0.28
- MACD
- ADVM 0.06
- ANEB -0.02
- Stochastic Oscillator
- ADVM 82.50
- ANEB 25.45
About ADVM Adverum Biotechnologies Inc.
Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.